Current Pharmaceutical Design

The Future of Medical Imaging
pp. 5487-5488(2)
Author: Landini, Luigi

Mineralocorticoid Receptor Antagonists in Cardiovascular Medicine: Looking for the Forest Among the Trees
pp. 5489-5490(2)
Authors: Stavropoulos, Konstantinos V.; Imprialos, Konstantinos P.; Doumas, Michael; Faselis, Charles J.

The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease
pp. 5491-5499(9)
Authors: Pantelidis, Panteleimon; Sideris, Michail; Viigimaa, Margus; Avranas, Konstantinos; Deligkaris, Pavlos; Zografou, Ioanna; Lovic, Dragan

Mineralocorticoid Receptor Antagonists in Essential and Resistant Hypertension
pp. 5500-5507(8)
Authors: Imprialos, Konstantinos P.; Bouloukou, Sofia; Kerpiniotis, Georgios; Katsimardou, Alexandra; Patoulias, Dimitrios; Bakogiannis, Constantinos; Faselis, Charles

Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
pp. 5508-5516(9)
Authors: Stavropoulos, Konstantinos; Papadopoulos, Christodoulos; Koutsampasopoulos, Konstantinos; Lales, Georgios; Mitas, Christos; Doumas, Michael

The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction
pp. 5517-5524(8)
Authors: Papademetriou, Vasilios; Toumpourleka, Maria; Imprialos, Konstantinos P.; Alataki, Sofia; Manafis, Alexandros; Stavropoulos, Konstantinos

The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
pp. 5525-5527(3)
Authors: Papagiannis, Achilleas; Alkagiet, Stelina; Tziomalos, Konstantinos

Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives
pp. 5528-5536(9)
Authors: Sarafidis, Pantelis A.; Memmos, Evangelos; Alexandrou, Maria-Eleni; Papagianni, Aikaterini

Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
pp. 5537-5541(5)
Authors: Kallistratos, Manolis S.; Pittaras, Andreas; Theodoulidis, Iakovos; Grassos, Charris; Poulimenos, Leonidas E.; Manolis, Athanasios J.

Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia
pp. 5542-5547(6)
Authors: Athyros, Vasilios G.; Sachinidis, Alexandros G.; Zografou, Ioanna; Simoulidou, Elisavet; Piperidou, Alexia; Stavropoulos, Nikiforos; Karagiannis, Asterios

Future Anti-aldosterone Agents
pp. 5548-5554(7)
Authors: Dimitriadis, Kyriakos; Tsioufis, Constantinos; Iliakis, Panayotis; Kasiakogias, Alexandros; Andrikou, Ioannis; Leontsinis, Ioannis; Konstantinidis, Dimitrios; Tousoulis, Dimitrios

Potent Cytotoxic Natural Flavonoids: The Limits of Perspective
pp. 5555-5579(25)
Authors: Taleghani, Akram; Tayarani-Najaran, Zahra

Design, Synthesis, Pharmacological Evaluation and Vascular Effects of Delphinidin Analogues
pp. 5580-5589(10)
Authors: Legeay, Samuel; Trân, Kien; Abatuci, Yannick; Justiniano, Hélène; Lugnier, Claire; Duval, Olivier; Helesbeux, Jean-Jacques; Faure, Sébastien

10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein
pp. 5590-5597(8)
Authors: Lee, Dong-Hwan; Hasanuzzaman, Md.; Kwon, Daeho; Choi, Hye-Young; Kim, So M.; Kim, Dong Jin; Kang, Dong Ju; Hwang, Tae-Ho; Kim, Hyung-Hoi; Shin, Ho Jung; Shin, Jae-Gook; Oh, Sangtae; Lee, Seokjoon; Kim, So Won

Acknowledgement to Reviewers
pp. 5598-5604(7)